NCT05735431View on ClinicalTrials.gov

Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

June 30, 2026

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Moderate Asthma
Interventions
DRUG

Administration of investigation drug

Participants randomized to this group will receive 1 inhalation of the product, twice daily, for 12 weeks.

DRUG

Administration of comparator

Participants randomized to this group will receive 1 inhalation of the product, twice daily, for 12 weeks.

Trial Locations (1)

06696-000

Eurofarma Laboratorios S.A, São Paulo

Sponsors
All Listed Sponsors
lead

Eurofarma Laboratorios S.A.

INDUSTRY